Firstly, regarding the expression of purinergic receptors, our data indicate that upon the progression of AD in 3xTg mice, a significant three-fold increase in the relative expression of P2Y13 receptor mRNA compared to expression in control WT animals occurs (Figure 2). The gene discussed is P2RX2; the disease is Alzheimer disease.